<p>随着全球市场因贸易谈判和经济指标而发生变化，亚洲市场因其独特的动态和机会而备受关注。在这种环境下，识别具有强大基本面和增长潜力的股票尤其具有回报，特别是在投资者寻求应对不断变化的市场格局时。</p>
<h3>亚洲十大未被发现的基本面强劲的宝藏股</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>湖北三峡旅游集团</td>
<td>11.24%</td>
<td>-15.32%</td>
<td>17.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>韩国评级</td>
<td>NA</td>
<td>0.74%</td>
<td>1.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>小西</td>
<td>0.15%</td>
<td>0.46%</td>
<td>12.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>红绵智慧科技创新有限公司（广州）</td>
<td>11.90%</td>
<td>-28.99%</td>
<td>46.16%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>安吉食品</td>
<td>NA</td>
<td>9.94%</td>
<td>-16.40%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>JHT 设计有限公司</td>
<td>2.19%</td>
<td>33.65%</td>
<td>-8.51%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>上海海鑫集团</td>
<td>0.78%</td>
<td>-0.42%</td>
<td>8.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>广东天德医疗电子</td>
<td>18.69%</td>
<td>-7.58%</td>
<td>-3.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳龙科技智能控制</td>
<td>8.06%</td>
<td>18.09%</td>
<td>13.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳东拓供应链管理</td>
<td>73.12%</td>
<td>-30.87%</td>
<td>-1.20%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们亚洲未被发现的基本面强劲的宝藏股筛选器中的 2704 只股票的完整列表。</p>
<p>在这里，我们突出了一部分我们筛选器中首选的股票。</p>
<h2>上海康耐视光学（SEHK:2276）</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 上海康耐视光学有限公司是一家在多个地区（包括中国大陆、美洲、亚洲、欧洲、大洋洲和非洲）制造和销售树脂眼镜镜片的公司，市值为 124.1 亿港元。</p>
<p><strong>运营：</strong> 上海康耐视光学的主要收入来源于树脂眼镜镜片的制造和销售，收入为 20.6 亿人民币。</p>
<p>上海康耐视光学最近的表现描绘了一幅乐观的图景，盈利增长 31%，超过医疗设备行业的 9.6%。该公司 2024 年的净收入达到 4.2828 亿人民币，较去年 3.2702 亿人民币显著增长，而基本每股收益从 0.77 元上升至 1.03 元。其债务的利息支付由 EBIT 以超过 104 倍的比率良好覆盖，突显了该小型企业在亚洲繁忙市场环境中的强大财务健康和稳定性。</p>
<ul>
<li>点击这里了解上海康耐视光学的细微差别，查看我们的详细分析健康报告。</li>
<li>通过访问我们的历史表现报告，评估上海康耐视光学的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth"/></p>
<p>SEHK:2276 截至 2025 年 5 月的盈利和收入增长</p>
<h2>博创科技（SZSE:300548）</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 博创科技有限公司专注于光通信集成光电设备的研究、开发、生产和销售，市值约为 131.6 亿人民币。</p>
<p><strong>运营：</strong> 博创科技的收入主要来自光通信集成光电设备的销售。公司的净利润率显示出显著的趋势，反映其财务表现的动态。</p>
<p>博创科技作为科技行业的一个重要参与者，最近展示了令人印象深刻的增长，过去一年盈利增长 309.9%，远超行业平均的-2.1%。目前交易价格比其估计的公允价值低 47%，为寻求被低估资产的投资者提供了一个引人注目的机会。该公司报告第一季度销售额为 5.3851 亿人民币，净收入为 8970 万人民币，较去年数据显著跃升。尽管最近股价波动，博创的财务健康得益于现金超过总债务和正的自由现金流状态。</p>
<ul>
<li>在我们的健康报告中更深入地了解博创科技的潜力。</li>
<li>通过查看我们的历史表现报告，获取博创科技的历史表现见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300548 截至 2025 年 5 月的盈利和收入增长</p>
<h2>DTS（TSE:9682）</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> DTS Corporation 是一家日本公司，专注于系统集成服务，市值为 1839.6 亿日元。</p>
<p><strong>运营：</strong> 该公司主要通过其系统集成服务产生收入。市值为 1839.6 亿日元。</p>
<p>DTS 作为 IT 行业的小型但有前景的参与者，正在进行战略性举措，专注于创新和股东价值。该公司报告过去一年盈利增长 45.8%，超过行业平均的 10.8%。目前交易价格比其公允价值估计低 10.2%，相较于同行提供了良好的相对价值。最近的股票回购计划旨在在 2025 年 7 月之前回购 75 万股，金额为 25 亿日元，提高资本效率和股东回报。组织变革强调生成式 AI 倡议和全球业务扩展，以推动未来的增长机会。</p>
<ul>
<li>在这份健康报告中解锁我们对 DTS 股票分析的全面见解。</li>
<li>了解 DTS 的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth"/></p>
<p>TSE:9682 截至 2025 年 5 月的盈利和收入增长</p>
<h2>利用机会</h2>
<ul>
<li>点击这里解锁我们全面的 2704 个亚洲未被发现的优质股票名单，具有强大的基本面。</li>
<li>持有这些公司的股票？在 Simply Wall St 上设置您的投资组合，以无缝跟踪您的投资并接收个性化的投资组合表现更新。</li>
<li>使用 Simply Wall St 提升您的投资组合，这是寻求全球市场覆盖的投资者的终极应用程序。</li>
</ul>
<h2>寻找新的视角？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>如果您想交易 DTS，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在超过 200 个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
<p>赞助内容</p>

长芯博创

9682

<p>这篇文章强调了三只具有强劲增长潜力的亚洲股票：上海康耐视光学、博创科技和 DTS 公司。上海康耐视光学市值为 124.1 亿港元，报告了 31% 的盈利增长，而博创科技的盈利增长则达到了惊人的 309.9%。DTS 公司的市值为 1839.6 亿日元，实现了 45.8% 的盈利增长。每家公司都展现出强大的基本面，并在各自的市场中处于良好位置，使它们成为寻求被低估资产的投资者在亚洲市场中的有吸引力的选择</p>

<p>As global markets experience shifts driven by trade negotiations and economic indicators, Asian markets are drawing attention with their unique dynamics and opportunities. In this environment, identifying stocks with strong fundamentals and growth potential can be particularly rewarding, especially as investors seek to navigate the evolving landscape.</p>
<div class="lb-trans"><p>随着全球市场因贸易谈判和经济指标而发生变化，亚洲市场因其独特的动态和机会而备受关注。在这种环境下，识别具有强大基本面和增长潜力的股票尤其具有回报，特别是在投资者寻求应对不断变化的市场格局时。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals In Asia</h3>
<div class="lb-trans"><h3>亚洲十大未被发现的基本面强劲的宝藏股</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hubei Three Gorges Tourism Group</td>
<td>11.24%</td>
<td>-15.32%</td>
<td>17.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Korea Ratings</td>
<td>NA</td>
<td>0.74%</td>
<td>1.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Konishi</td>
<td>0.15%</td>
<td>0.46%</td>
<td>12.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou</td>
<td>11.90%</td>
<td>-28.99%</td>
<td>46.16%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Anji Foodstuff</td>
<td>NA</td>
<td>9.94%</td>
<td>-16.40%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>JHT DesignLtd</td>
<td>2.19%</td>
<td>33.65%</td>
<td>-8.51%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Shanghai Haixin Group</td>
<td>0.78%</td>
<td>-0.42%</td>
<td>8.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Guangdong Transtek Medical Electronics</td>
<td>18.69%</td>
<td>-7.58%</td>
<td>-3.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Shenzhen Longtech Smart Control</td>
<td>8.06%</td>
<td>18.09%</td>
<td>13.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Shenzhen Easttop Supply Chain Management</td>
<td>73.12%</td>
<td>-30.87%</td>
<td>-1.20%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>湖北三峡旅游集团</td>
<td>11.24%</td>
<td>-15.32%</td>
<td>17.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>韩国评级</td>
<td>NA</td>
<td>0.74%</td>
<td>1.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>小西</td>
<td>0.15%</td>
<td>0.46%</td>
<td>12.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>红绵智慧科技创新有限公司（广州）</td>
<td>11.90%</td>
<td>-28.99%</td>
<td>46.16%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>安吉食品</td>
<td>NA</td>
<td>9.94%</td>
<td>-16.40%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>JHT 设计有限公司</td>
<td>2.19%</td>
<td>33.65%</td>
<td>-8.51%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>上海海鑫集团</td>
<td>0.78%</td>
<td>-0.42%</td>
<td>8.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>广东天德医疗电子</td>
<td>18.69%</td>
<td>-7.58%</td>
<td>-3.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳龙科技智能控制</td>
<td>8.06%</td>
<td>18.09%</td>
<td>13.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳东拓供应链管理</td>
<td>73.12%</td>
<td>-30.87%</td>
<td>-1.20%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 2704 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>点击这里查看我们亚洲未被发现的基本面强劲的宝藏股筛选器中的 2704 只股票的完整列表。</p>
</div><p>Here we highlight a subset of our preferred stocks from the screener.</p>
<div class="lb-trans"><p>在这里，我们突出了一部分我们筛选器中首选的股票。</p>
</div><h2>Shanghai Conant Optical (SEHK:2276)</h2>
<div class="lb-trans"><h2>上海康耐视光学（SEHK:2276）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Shanghai Conant Optical Co., Ltd. is a company that manufactures and sells resin spectacle lenses across multiple regions including Mainland China, the Americas, Asia, Europe, Oceania, and Africa with a market capitalization of HK$12.41 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 上海康耐视光学有限公司是一家在多个地区（包括中国大陆、美洲、亚洲、欧洲、大洋洲和非洲）制造和销售树脂眼镜镜片的公司，市值为 124.1 亿港元。</p>
</div><p><strong>Operations:</strong> The primary revenue stream for Shanghai Conant Optical comes from the manufacturing and sales of resin spectacle lenses, generating CN¥2.06 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 上海康耐视光学的主要收入来源于树脂眼镜镜片的制造和销售，收入为 20.6 亿人民币。</p>
</div><p>Shanghai Conant Optical's recent performance paints a promising picture, with earnings growth of 31% outpacing the Medical Equipment industry's 9.6%. The company's net income for 2024 reached CNY 428.28 million, a notable increase from CNY 327.02 million in the previous year, while basic earnings per share rose to CNY 1.03 from CNY 0.77. Interest payments on its debt are well-covered by EBIT at an impressive ratio of over 104 times, highlighting strong financial health and stability within this small cap entity in Asia's bustling market landscape.</p>
<div class="lb-trans"><p>上海康耐视光学最近的表现描绘了一幅乐观的图景，盈利增长 31%，超过医疗设备行业的 9.6%。该公司 2024 年的净收入达到 4.2828 亿人民币，较去年 3.2702 亿人民币显著增长，而基本每股收益从 0.77 元上升至 1.03 元。其债务的利息支付由 EBIT 以超过 104 倍的比率良好覆盖，突显了该小型企业在亚洲繁忙市场环境中的强大财务健康和稳定性。</p>
</div><ul>
<li>Click here to discover the nuances of Shanghai Conant Optical with our detailed analytical health report.</li>
<li>Evaluate Shanghai Conant Optical's historical performance by accessing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里了解上海康耐视光学的细微差别，查看我们的详细分析健康报告。</li>
<li>通过访问我们的历史表现报告，评估上海康耐视光学的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth"/></p>
<p>SEHK:2276 Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>SEHK:2276 截至 2025 年 5 月的盈利和收入增长</p>
</div><h2>Broadex Technologies (SZSE:300548)</h2>
<div class="lb-trans"><h2>博创科技（SZSE:300548）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Broadex Technologies Co., Ltd. focuses on the research, development, production, and sale of integrated optoelectronic devices for optical communications both in China and globally, with a market cap of approximately CN¥13.16 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 博创科技有限公司专注于光通信集成光电设备的研究、开发、生产和销售，市值约为 131.6 亿人民币。</p>
</div><p><strong>Operations:</strong> Broadex Technologies generates revenue primarily from the sale of integrated optoelectronic devices for optical communications. The company's net profit margin has shown notable trends, reflecting its financial performance dynamics.</p>
<div class="lb-trans"><p><strong>运营：</strong> 博创科技的收入主要来自光通信集成光电设备的销售。公司的净利润率显示出显著的趋势，反映其财务表现的动态。</p>
</div><p>Broadex Technologies, a notable player in the tech sector, recently showcased impressive growth with earnings rising 309.9% over the past year, far outpacing the industry average of -2.1%. Trading at 47% below its estimated fair value, it presents an intriguing opportunity for investors seeking undervalued assets. The company reported first-quarter sales of CNY 538.51 million and net income of CNY 89.7 million, a significant leap from last year's figures. Despite a volatile share price recently, Broadex's financial health is bolstered by having more cash than total debt and positive free cash flow status.</p>
<div class="lb-trans"><p>博创科技作为科技行业的一个重要参与者，最近展示了令人印象深刻的增长，过去一年盈利增长 309.9%，远超行业平均的-2.1%。目前交易价格比其估计的公允价值低 47%，为寻求被低估资产的投资者提供了一个引人注目的机会。该公司报告第一季度销售额为 5.3851 亿人民币，净收入为 8970 万人民币，较去年数据显著跃升。尽管最近股价波动，博创的财务健康得益于现金超过总债务和正的自由现金流状态。</p>
</div><ul>
<li>Take a closer look at Broadex Technologies' potential here in our health report.</li>
<li>Gain insights into Broadex Technologies' historical performance by reviewing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的健康报告中更深入地了解博创科技的潜力。</li>
<li>通过查看我们的历史表现报告，获取博创科技的历史表现见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300548 Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>SZSE:300548 截至 2025 年 5 月的盈利和收入增长</p>
</div><h2>DTS (TSE:9682)</h2>
<div class="lb-trans"><h2>DTS（TSE:9682）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> DTS Corporation is a Japanese company specializing in systems integration services with a market capitalization of ¥183.96 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> DTS Corporation 是一家日本公司，专注于系统集成服务，市值为 1839.6 亿日元。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily through its systems integration services. It has a market capitalization of ¥183.96 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过其系统集成服务产生收入。市值为 1839.6 亿日元。</p>
</div><p>DTS, a small but promising player in the IT sector, has been making strategic moves with a focus on innovation and shareholder value. The company reported impressive earnings growth of 45.8% over the past year, outpacing the industry average of 10.8%. Trading at 10.2% below its fair value estimate, DTS offers good relative value compared to peers. A recent share repurchase plan aims to buy back 750,000 shares for ¥2.5 billion by July 2025, enhancing capital efficiency and shareholder returns. Organizational changes emphasize generative AI initiatives and global business expansion to drive future growth opportunities.</p>
<div class="lb-trans"><p>DTS 作为 IT 行业的小型但有前景的参与者，正在进行战略性举措，专注于创新和股东价值。该公司报告过去一年盈利增长 45.8%，超过行业平均的 10.8%。目前交易价格比其公允价值估计低 10.2%，相较于同行提供了良好的相对价值。最近的股票回购计划旨在在 2025 年 7 月之前回购 75 万股，金额为 25 亿日元，提高资本效率和股东回报。组织变革强调生成式 AI 倡议和全球业务扩展，以推动未来的增长机会。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of DTS stock in this health report.</li>
<li>Learn about DTS' historical performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这份健康报告中解锁我们对 DTS 股票分析的全面见解。</li>
<li>了解 DTS 的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth"/></p>
<p>TSE:9682 Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>TSE:9682 截至 2025 年 5 月的盈利和收入增长</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Unlock our comprehensive list of 2704 Asian Undiscovered Gems With Strong Fundamentals by clicking here.</li>
<li>Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.</li>
<li>Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里解锁我们全面的 2704 个亚洲未被发现的优质股票名单，具有强大的基本面。</li>
<li>持有这些公司的股票？在 Simply Wall St 上设置您的投资组合，以无缝跟踪您的投资并接收个性化的投资组合表现更新。</li>
<li>使用 Simply Wall St 提升您的投资组合，这是寻求全球市场覆盖的投资者的终极应用程序。</li>
</ul>
</div><h2>Searching for a Fresh Perspective?</h2>
<div class="lb-trans"><h2>寻找新的视角？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>If you're looking to trade DTS, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 DTS，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在超过 200 个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

探索三只具有强劲潜力的亚洲股票